In Silico Assessment Of Porphyrins Against Sars-Cov-2 Main Protease: Adme, Pass And Docking Studies
International Journal of Drug Delivery Technology · 18.05.2026 · 16 (28s)
DOI: 10.25258/ijddt.16.28s.93 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 18.05.2026. Verfasst von D. Rekha und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Two porphyrins, meso-5,10,15,20-tetrakis(p-hydroxyphenyl) porphyrin [T(p−OH) PP] and meso5,10,15,20-tetrakis(p-bromophenyl) porphyrin [T(p−Br) PP], were investigated using integrated in silico approaches to evaluate their antiviral potential and safety profiles. Molecular docking against the COVID-19 main protease (PDB ID: 5R7Y) revealed strong binding affinities, with binding free energies of −159.06 and −163.39 kcal/mol. ADMET analysis using Swiss ADME and pkCSM demonstrated favourable pharmacokinetic properties, including good solubility, high intestinal absorption, and compliance with Lipinski’s rule of five. PASS predictions indicated broad biological activity, particularly involving redox enzyme inhibition and receptor antagonism. Carcinogenicity assessment using Carcino-Pred-EL ensemble models consistently classified both compounds as non-carcinogenic. Collectively, these findings highlight the promising therapeutic potential of the studied porphyrins and support further experimental validation.
Zitieren
APA
Rekha, D., Arun, T., & Reddy, Y. R. (2026). In Silico Assessment Of Porphyrins Against Sars-Cov-2 Main Protease: Adme, Pass And Docking Studies. International Journal of Drug Delivery Technology, 16(28s). https://doi.org/10.25258/ijddt.16.28s.93
Vancouver
Rekha D, Arun T, Reddy YR. In Silico Assessment Of Porphyrins Against Sars-Cov-2 Main Protease: Adme, Pass And Docking Studies. International Journal of Drug Delivery Technology. 2026;16(28s). doi:10.25258/ijddt.16.28s.93
BibTeX
@article{Rekha2026,
author = {Rekha, D. and Arun, T. and Reddy, Y.V. Rami},
title = {In Silico Assessment Of Porphyrins Against Sars-Cov-2 Main Protease: Adme, Pass And Docking Studies},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {28s},
doi = {10.25258/ijddt.16.28s.93}
}
EUVIMED